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Summary  
In diarthrodial joints, bone and cartilage are structurally and functionally inseparable as shown in osteoarthritis (OA), 
where subchondral bone changes are integral in the disease process. By ultrastructural immunohistochemistry using 
polyclonal antibodies against guinea-pig bone sialoprotein (BSP), we investigated the distribution of this matrix 
protein at the osteocartilaginous interface in Hartley guinea-pig knees at different stages of primary osteoarthritis. 
Between 6 and 12 months they developed moderate osteoarthritic changes predominantly in the medial condyle, 
progressing to severe OA at 30 months. In all age groups BSP labeling was concentrated to the osteocartilaginous 
interface at a i pm narrow zone at the interface. In the medial osteoarthritic condyle, BSP was increased as compared 
with the lateral nonosteoarthritic condyle, but only at 30 months, when cartilage fibrillation correlated to BSP. Our 
observations suggest that altered BSP abundance may be a potential bone marker for late stage OA, while early events 
in bone cannot be monitored. BSP is expressed early in osteogenesis and may have a role in biological mineralization 
and growth. Since a sharp zone of intense BSP labeling remains at a remarkably constant level throughout life in 
guinea-pigs, BSP may have an important structural and/or regulating role at the interface. The protein n~ay act as 
an anchor of calcified articular cartilage to subchondral bone or by regulating mineralization at the osteocartilaginous 
interface. 
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Int roduct ion 
CLINICALLY, osteoarthr i t is  (OA) has been described 
as an unspecific end stage of organ failure [27]. 
Various animal models of OA have been designed 
[1]. Most of these models involve an intra-art icular  
intervent ion result ing in rapidly progressive 
changes, quite unlike pr imary OA. There are, 
however, natural ly  occurr ing OA-like conditions 
in animals, e.g., Hart ley guinea-pigs [4]. The 
importance of subchondral  bone changes in OA 
pathogenesis has previously been stressed [10, 27]. 
Early subchondral  bone t rabecular  thickening 
simultaneous with cart i lage changes have been 
shown by microscopic omputed tomography [11]. 
Clinically, subchondral  sclerosis is the first 
reliable radiographic sign of OA and it has been 
suggested to preceed joint space narrowing [25]. 
Magnetic resonance imaging has shown a consist- 
ent increased thickness of sclerotic bone with 
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osteoarthr it is  [35]. The need for molecular  markers  
for monitor ing the OA process is evident [13]. 
Work has been concentrated on cart i lage markers  
[6, 18], whereas markers  of bone turnover  have 
until  recently mainly been used to monitor  other 
diseases like osteoporosis [12]. 
Bone contains several proteins with high 
contents of sialic acid-containing ol igosacchar- 
ides which may regulate matr ix assembly and 
mineral izat ion [16]. These include, bone sialo- 
protein (BSP) and osteopontin, which have both 
been purified and character ized ur ing the last 
decade [15]. 
BSP is rather  restr icted in its distr ibution to 
bone, with undetectable levels of expression in 
most other tissues, with the possible exception of 
hypertrophic chondrocytes [7, 9]. Its an acidic, 
phosphorylated and sulfated glycoprotein, r ich in 
sialic acid. The core protein has a molecular  
weight of approximately 32 kDa. In-situ hybridiz- 
ation studies have demonstrated BSP mRNA early 
in bone formation and BSP has therefore been 
suggested to have a role in early osteogenesis [19]. 
The protein has also been ascribed a role in 
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biological mineralization [7]. Clinically, BSP 
shows increased turnover in joint disease, and 
increased amounts are released into the synovial 
fluid in rheumatoid arthritis [29], and into serum in 
OA [26]. 
Since tissue compartments containing BSP 
appear to show altered turnover in joint disease, 
we have utilized studies of BSP release as an 
indicator of early involvement ofthe osteocartilag- 
inous interface in guinea-pig OA. 
Materials and Methods 
BSP ISOLATION 
Diaphyseal bones from the lower limbs from 2 
month-old Dunkin Hartley guinea-pigs (N=10), 
killed by intraperitoneal injections of pentobarbi- 
tal, as approved by the Local Animal Care Ethical 
Committee, were frozen, powderized and kept in 
-20~ over night. The bone powder (50 g) was 
extracted sequentially with 10 volumes of 4M 
guanidine/HC1, 50raM sodium acetate, 0.1m s- 
ACA, 5raM benzamidine, pH5.8, followed by 
extraction in 30 volumes of 4 M guanidine/HC1, 
50raM Tris/HC1, 0.1M s-ACA, also containing 
0.5M-trisodium EDTA, and 5mM benzamidine, 
pH 7.4 [14]. Both extraction solvents were sup- 
plemented with proteinase inhibitors and with 
5.4 mM N-ethylmaleimide [17]. The second extract 
was then concentrated at 4~ by ultrafiltration 
over a PM-10 filter (Amicon Corp., Lexington, MA, 
U.S.A.). The material retained was brought into 
7M urea, 0.1 M sodium acetate, 10mM Tris/HC1 
buffer, pH 6.0, by diaflow with 10 volumes of the 
urea solution. 
The guanidine HC1/EDTA-extract, brought into 
7 M urea/Tris buffer was chromatographed on a 
DEAE-sepharose ion-exchange column (Whatman 
Chemicals, Maidstone, Kent, U.K.) [15]. Bound 
material was eluted with a linear salt gradient 
(500 ml) ranging from 0 1.0 M sodium chloride in 
7 M Urea, 10 mM Tris, pH 6.0. Fractions of 15 ml 
were collected and analyzed for protein by their 
absorbance at 280 nm. 
Representative samples from the fractions were 
analyzed by sodium dodecyl sulfate/polyacryl- 
amide gel electrophoresis (SDS-PAGE) under 
non-reducing conditions to identify the elution 
position of BSP. Gradient polyacrylamide (4- 
16%) slab gels which were cast with a 4% 
stacking gel and SDS buffer system were used 
[22]. Fractions containing predominantly BSP, 
were pooled and taken to immunization of 
rabbits to prepare polyclonal antibodies. 
ANTIBODY PREPARATION 
Antiserum was raised against BSP by immuniz~ 
ing rabbits with the isolated fractions containing 
BSP (50/~g), as approved by the Local Animal Care 
Ethical Committee. Initial immunization was with 
Freund's complete adjuvant (Difco Laboratories, 
Detroit, MI, U.S.A.) and subsequent boosters, after 
4 and 8 weeks, were with Freund's incomplete 
adjuvant (Difco Laboratories). 
SDS-PAGE and Western blot analyses were used 
to test the specificity of the antibodies. A sample of 
the crude guanidine HC1/EDTA extract was 
precipitated with ethanol and electrophoresed on
a gradient SDS-polyacrylamide g l, as described 
elsewhere [29]. Proteins in the gel were electro- 
phoretically transblotted to nitrocellulose and 
processed for positive immunodetection with the 
antiserum, essentially as described by Towbin [33] 
using a 1:200 dilution of rabbit anti-guinea-pig 
BSP and a 1:500 dilution of peroxidase conjugated 
pig anti-rabbit IgG (DAKO, Denmark). Only one 
immunoreactive band was observed with the 
guanidine HC1/EDTA extract of guinea-pig bone. 
Its migration corresponds to that of BSP. 
ULTRASTRUCTURAL IMMUNOHISTOCHEMISTRY 
Three outbred male Hartley guinea-pigs 
(Molleg&rd, Copenhagen, Denmark) from each of 
three age groups: 6 (adult), 12 (middle aged) and 30 
(old) months of age were used. Mean (SD) body 
weights were 960 (60) g, 1160 (50) g, and 1230 (90) g. 
The animals were heparinized (L6vens lfikemedel, 
Malm6, Sweden), anesthetized by fentanyl-- 
fluanison/H20 (Hypnorm, Leo, Helsingborg, Swe- 
den) and fixed by vascular perfusion as above using 
0.1M phosphate-buffered fixative of 0.3% glu- 
taraldehyde and 0.3% para-formaldehyde, pH 7.4, 
containing 3% dextran T40 (Pharmacia, Uppsala, 
Sweden). Subsequently the proximal tibiae were 
dissected out. The specimens were cut sagittally 
into two approximately equal portions, i.e., medial 
and lateral plateaus. The central compartment 
comprised about 30% of the joint surface. Thin 
vertical slices including the cartilage and a 
minimal part of the subchondral bone were cut 
into small pieces and further fixed by immersion in 
the same fixative for 2 h at room temperature. The 
specimens were dehydrated in methanol and 
embedded at low temperature in the polar resin 
Lowicryl K11M (Chemische Werke Lowi GmbH, 
Waldkreiburg, Germany) [20]. Two ultrathin 
sections (35-40 ran) were cut from two independent 
blocks from each animal. The specimens were 
placed on formvar-coated nickel grids. After 
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blocking with 1% bovine serum albumin (BSA) and 
0.1% gelatin, the sections were incubated with 
antibodies in phosphate-buffered saline containing 
BSA [20]. All sections used for immunohistochem- 
istry were incubated simultaneously using the 
same stock of solutions. Positive immunostaining 
was detected by protein-A coated with 10 nm gold 
(Amersham, Buckinghamshire, UK). Sub- 
sequently, the sections were contrasted with 4% 
uranyl acetate and lead citrate. 
MEASUREMENTS 
Electron micrographs were sampled along the 
cartilage and the osteoid interface in articular 
cartilage by systemic random sampling [9]. The 
distributions of immunogold markers for BSP were 
studied on printed copies at a final magnification 
of 65 000. Three compartments were defined in the 
proximal epiphysis at the lower border of articular 
cartilage: mineralized cartilage, interface and 
bone. The interface was defined as the area 
between the cartilage-bone interface and a line 
drawn at a distance of 1/~m deep into the bone 
matrix (Fig. 2). Cartilage and bone compartments 
were defined as compartments on each side of the 
interface at an approximate distance of 5 pm and 
parallel to the border region [9]. 
The number of animals (3), blocks (3) and 
sections (1) were chosen after a pilot study using 
cumulative mean plots for evaluation. Eight 
micrographs were taken from each of three 
compartments from each section. In all, the data 
were based on more than 1300 micrographs. The 
labeling per unit area in each compartment in the 
medial and lateral condyles was calculated on 
printed copies. In addition, for ultrastructural 
analyses of the BSP labeling within the border 
region, the distance of each gold particle from the 
osteocartilaginous interface was measured with a 
semiautomatic mage analyzer (Videoplan, Zeiss, 
Germany). The 1 #m thin osteocartilaginous inter- 
face was divided into five equal intervals, each 
0.2 gm thin. 
Before embedding, sections for light microscopic 
evaluation were also made. Three to four decal- 
cified sections from each condyle from each animal 
were cut and stained with toluidine blue. Articular 
cartilage fibrillation and the calcified cartilage 
thickness were chosen as parameters of OA. Both 
have previously been reported to be increased in 
OA [10]. Cartilage fibrillation was measured by 
intersection counting with a cycloid grid for 
vertical sections [3], i.e., the number of intersec- 
tions through the item in question, divided by the 
number of intersections with the smooth contour 
of the joint surface. The thickness of the calcified 
cartilage was measured perpendicular to the joint 
surface. 
Analysis of variance, Tukey's test for correction 
for multiple comparisons, Kolmogorov Smirnov 
nonparametric test, and Pearsons test for corre- 
lation at a rejection level of 5% were used for 
statistical analyses. 
Resu l ts  
The 6-month-old animals showed no gross 
alterations typical for OA, i.e. surface fibrillation, 
cartilage destruction or bone sclerosis. However, 
at 12 months the central nonmeniscus covered 
portion of the medial plateaus had developed 
typical OA alterations, with a roughened cartilage 
surface, subchondral bone sclerosis and osteo- 
phytes at the joint margins (Fig. 1). In contrast, the 
lateral surface was smooth without signs of OA. In 
the medial condyle, the changes progressed, and at 
30 months there was subchondral bone eburnation. 
In the lateral condyle, only mild fibrillation was 
observed at 30 months. 
Calcified cartilage was always thicker in the 
lateral condyle compared with the medial (Table I). 
With increasing OA, calcified cartilage thickness 
increased both in the medial and lateral condyles, 
but without statistical significance in the lateral 
(non-OA) condyle. Cartilage fibrillation increased 
with progressive OA in the medial condyle, while 
in the lateral condyle values were low and ra ther  
FIG. 1. Histological section from the central nonmenis- 
cus covered portion of the medial plateau showing 
osteoarthritic (OA) changes in the guinea-pig proximal 
tibia, with cartilage fibrillation (F), increased calcified 
cartilage thickness (C), and subchondral bone sclerosis 
(S) at t2 months of age. The lateral plateau was not 
affected by OA. At 30 months of age, the changes 
progressed tosevere OA and included osteophytes at the 
joint margins. (Original magnification x125). 
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Table I 
Thickness of calcified cartilage in the central 
medial osteoarthritic (OA) and lateral 
(non-OA) condyles in different ages in 
guinea-pig proximal tibias 
Age Medial Lateral 
6 months 0.08 (0.01)* 0.15 (0.01) 
12 months 0.13 (0.02)t 0.18 (0.03) 
30 months 0.12 (0.01)$ 0.18 (0.02) 
Mean values (s.D.) mm (N=3) .  *P<0.05 
between medial and lateral condyle 6-months-old 
groups, tP < 0,05 between 6- and 12-months-old 
groups. :~P < 0,05 between 6- and 30-months-old 
groups. 
constant (Table II). BSP immunolabeling showed 
low levels in cartilage, a very sharp, several-fold 
increase at the interface, and then a sharp 
decrease in bone to levels three times those in 
cartilage (Fig. 2). In the lateral (non-OA) condyle, 
BSP immunolabeling decreased in the oldest group 
in the interface (Table III). There were no changes 
observed medially (Table III). The ultrastructural 
BSP distribution is displayed in Fig. 3. There was 
a correlation between cartilage fibrillation and 
BSP immunolabeling in the osteocartilaginous 
interface in the medial condyle (severe OA) in the 
30 months group (r 2 = 0.94). However, we could not 
observe any correlation between calcified cartilage 
thickness and BSP labeling, nor between fibrilla- 
tion and BSP immunolabeling in articular carti- 
lage and subchondral bone. 
Discuss ion  
The restricted BSP distribution to the osteo- 
cartilaginous interface corroborates previous find- 
ings from normal rat tibias [9]. In young rats with 
rapid bone turnover, BSP labeling increased about 
twofold between 21 and 32 days of age and then 
remained at the same level at 84 days [9]. In this 
study we tbund that the sharp gradient of BSP 
between cartilage and bone remained largely 
unchanged throughout life, with only a slight 
decrease with age in the lateral non-OA condyle in 
the oldest animals. This may be explained by the 
Table II 
Articular cartilage fibrillation in the central 
medial (OA) and lateral (non-OA) condyles 
Age Medial Lateral 
6 months 1.1 (0.1) 1.0 (0.0) 
12 months 2.0 (0.2)* 1.2 (0.0) 
30 months 1.7 (0.2)t 1.2 (0.2) 
Mean values (s.D.) ram/ram (N = 3). *P < 0.05 
between 6- and 12-months-old groups, fP < 0.05 
between 6- and 30-month-old groups. 
Fla. 2. Electron micrograph of bone sialoprotein (BSP) 
immunolabeling from a 12 month-old guinea-pig (proxi- 
mal tibia). BSP immunolabeling was highest in the 
interface (I) between cartilage and bone, lower in 
subchondral bone (S), and at background levels in 
cartilage (C). (Original magnification x65 000). 
fact that old guinea-pigs have less bone turnover, 
as compared with the relatively younger rats, 
which still exhibit bone growth and higher bone 
turnover. As discussed elsewhere [19], it is likely 
that BSP binds to c~ at the interface, 
becoming fixed at this site. The roles this confer to 
BSP are unclear, but the protein may regulate 
processes at the interface, and/or act as an anchor 
of calcified articular cartilage to subchondral 
bone, e.g., regulating mineralization at the 
osteocartilaginous interface. 
BSP labeling was higher in the osteocartilagi- 
nous interface in the medial condyle with 
advanced OA as compared with the lateral condyle 
with only superficial fibrillation. This is in line 
with previous studies implicating the importance 
of subchondral bone changes in the OA pathogen~ 
esis [27]. However, there was no difference in BSP 
labeling between condyles in the 12-month-old 
group with moderate OA changes. These findings 
suggest hat BSP may be a bone marker for late 
stage OA, while early events in bone do not result 
in altered deposition of BSP. This is supported by 
the fact that serum BSP is increased in patients 
with radiographic OA, but normal at an earlier 
stage without radiographic pathology [26]. In 
severe rheumatoid arthritis (RA), BSP in synovial 
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Table III 
Distribution of BSP immunolabeling in different compartments in the central medial (OA) and lateral 
~'~ (non-OA) tibial condyles 
Cartilage Interface Bone 
Age Medial Lateral Medial Lateral Medial Lateral 
6 months 0.4 (0.2) 0.3 (0.1) 9.5 (0.4) 9.3 (0.1) 1.0 (0.3) 1.3 (0.1) 
12 months 0.4 (0.2) 0.3 (0.1) 9.3 (0.5) 9.5 (0.1) 1.2 (0.4) 1.0 (0.1) 
30 months 0.4 (0.1) 0.6 (0.4) 9.4 (0.1)$ 8.9 (0.1)*t 1.2 (0.1) 1.3 (0.2) 
Mean value (S.D.) for goldmarkers per area unit (N = 3). *P < 0.05 between 6 and 30 months groups. %P < 0.05 between 
12 and 30 months groups, ~P < 0.05 between lateral and medial condyles. 
fluid is increased with progressive joint damage 
[29]. This is probably the result of a much more 
rapid degree of bone destruction in RA as opposed 
to OA. BSP concentrat ion increases in patients 
with progressive OA, but remains constant in 
patients showing no progression [26]. This may 
indicate that the early changes in subchondral 
bone may be related to altered turnover, rather 
than altered composition, in view of the rather 
constant BSP-levels locally. 
The distinct feature of bone changes in OA have 
been pointed out [27]. Alterations in trabecular 
subchondral bone have been found as early as the 
first histologic carti lage changes detectable by the 
use of microscopic computed tomography in 
studies of the hindlimb myectomy OA model [11]. 
The progression of bone pathology in OA, as 
measured by increase in subchondral bone thick- 
1.0 
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FIG. 3. Bars illustrating the BSP immunolabeling within 
the 04).2 pm interval of the interface between articular 
cartilage and subchondral bone. The ratio BSP labeling 
medial/lateral condyle increased with increasing OA 
between 6- and 30-month-old groups (*P < 0.05). Mean 
values (s.m) for goldmarkers per area unit (N= 3). 
ness, has been verified by magnetic resonance 
imaging of developing changes in guinea-pig OA 
[35]. 
The normal osteocarti laginous interface is 
irregular and coral-like. In guinea-pig OA this 
surface flattens [8], most likely as the result of an 
ongoing remodeling. If BSP labeling is related to 
the surface density of the interface, the difference 
between the medial and lateral condyles at 30 
months further increases. This is consistent with 
the suggested early event in OA being a pathologic 
disturbance in tissue remodeling activity at the 
cart i lage-bone interface [21], where there is a 
marked concentrat ion of shear stress [5,23]. 
Subchondral  bone stiffening increases the shear 
stresses in the overlying art icular carti lage [2]. 
We observed a correlat ion between BSP labeling 
and carti lage fibril lation [10], which corroborates 
the notion that carti lage and bone changes are 
parallel in OA. Coincident changes in art icular 
carti lage and subchondral bone in progressive OA 
have been observed by bone scintigraphy and 
measurements of serum levels of carti lage 
oligomeric matrix protein (COMP) [31]. Previous 
studies have reported an increase of the calcified 
carti lage thickness in human OA [34], as well as in 
guinea-pig OA [8]. In OA a correlat ion has been 
shown between an increased calcified carti lage 
thickness and trabecular bone volume [24] which 
suggests an increased bone metabolism. 
Although much attent ion has been given to 
biochemical markers of both bone formation and 
bone resorption in different metabolic diseases 
such as osteoporosis [12], studies in OA have been 
scarce [26]. Markers such as osteocalcin [30] and 
pyridinium cross-links of collagen appear to have 
limited applications in early OA [28]. In cart i lage 
there is an abundance of potential specific matrix 
markers, COMP [31], keratan sulfate [for review 
see 32], and novel epitopes, i.e., chondroit in sulfate 
fragments uch as 3B3 [6]. However, in view of the 
increased importance of bone changes in the OA 
pathogenesis, further studies of OA bone markers 
are clearly needed. 
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